Evidence map›Paper›PMID 29969646›Full record

ArticleMagnetic resonance imaging2018

Quantitative analysis of peri-tumor fat in different molecular subtypes of breast cancer.

Jeon-Hor Chen, Yang Zhang, Siwa Chan, Ruey-Feng Chang, Min-Ying Su

Open access · greenAbstract read
In one paragraph

Article in Magnetic resonance imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Jeon-Hor ChenCenter For Functional Onco-Imaging of Department of Radiological Sciences, University of California, Irvine, CA, USA; Department of Radiology, E-Da Hospital and I-Shou University, Kaohsiung, Taiwan. Electronic address: jeonhc@uci.edu.
Yang ZhangCenter For Functional Onco-Imaging of Department of Radiological Sciences, University of California, Irvine, CA, USA.
Siwa ChanGraduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei, Taiwan; Department of Medical Imaging, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan; Department of Radiology, School of Medicine, Tzu Chi University, Hualien, Taiwan.
Ruey-Feng ChangGraduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei, Taiwan.
Min-Ying SuCenter For Functional Onco-Imaging of Department of Radiological Sciences, University of California, Irvine, CA, USA.
University of California, Irvine · USNational Taiwan University · TWTzu Chi University · TW

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
Prediction of Neoadjuvant Chemo Pathological Response Using MRI MarkersR01CA127927 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI SU, MIN-YING L. · 2008 to 2017
$5.0M
Mammographic Density and Metabolic Genotyping for Predicting Cancer PrognosisR21CA208938 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI CHEN, JEON-HOR, SU, MIN-YING L. · 2017 to 2018
$370k
Volume and Morphology of Fibroglandular Tissue for Breast Cancer Risk PredictionR21CA170955 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI CHEN, JEON-HOR, SU, MIN-YING L. · 2013 to 2014
$363k
Evaluation of 3D MRI-Based Quantitative Breast Density for ChemopreventionR03CA136071 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI CHEN, JEON-HOR · 2009 to 2010
$153k
NCI NIH HHS P30 CA062203NCI NIH HHS R01 CA127927NCI NIH HHS R03 CA136071NCI NIH HHS R21 CA170955NCI NIH HHS R21 CA208938
6 · The paper itself

Abstract

background and purposesThe aim of this study was to develop morphological analytic methods to analyze the tumor-fat interface and in different peritumoral shells away from the tumor, and to compare the results among three molecular subtypes of breast cancer. MATERIALS AND

methodsA total of 102 women (mean age 48.5 y/o) with solitary well-defined breast cancers were analyzed, including 46 human epidermal growth factor receptor 2 (HER2) (+), 46 HER2(-) hormonal receptor (HR) (+), and 10 triple negative (TN) breast cancers. The tumor lesion, the breast, the fibroglandular and fatty tissue were segmented using well-established methods. The whole breast fat percentage and the peri-tumor interface fat percentage were measured. Three shells (SH1, SH2, SH3) surrounding the convex hall of the three dimensional (3D) tumor were defined and in each shell the volumetric percentage of fat was calculated. The peri-tumor interface fat percentage and the volumetric percentage of fat in the three peri-tumoral shells were compared among different subtypes.

resultsIn the TN group, the fat percentage on the tumor boundary was 43 ± 20% and 78 ± 12% for two dimensional (2D) and 3D measurement, respectively, which were the highest among the three subtypes but not significantly different. The fat percentage in SH2 and SH3 in the TN group was 82 ± 7% and 85 ± 7%, which was significantly higher compared to the two other two subtypes. The results remained after controlling for the whole breast fat percentage.

conclusionsThis study provided a feasible method for quantitative analysis of peri-tumoral tissue characteristics. Because of small patient number, the finding that TN tumors had the highest peri-tumor fat content among the three subtypes needs to be further verified with a large cohort study.

Indexed as

Magnetic Resonance ImagingAdipose TissueAdultAgedBreastBreast NeoplasmsCohort StudiesErb-b2 Receptor Tyrosine KinasesFemaleHumansLipomaMiddle AgedReceptors, EstrogenRetrospective StudiesTriple Negative Breast NeoplasmsYoung AdultERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesReceptors, Estrogen

Identifiers

PMID29969646
PMCPMC6684233
OpenAlexW2810250569

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.